Novartis Ruling In India Could Spark Larger Movement Against Patent Trolling

By: Tuesday April 2, 2013 8:30 am

So let’s say you are a leading multinational pharmaceutical company and you have a blockbuster cancer drug. You patent the drug, make tremendous profits, but now the clock is ticking and the patent is set to expire. What do you do?

If you are Novartis and your blockbuster cancer drug is Gleevec you are going to engage in a common practice in the pharmaceutical industry – as well as other intellectual property dependent industries – known as evergreening. A few tweaks here, a few tweaks there, and voila reset the clock. The patent is back in effect and the money can keep rolling in. Why spend money on developing new drugs when you can spend just a fraction of that cost on legal bills defending your tweaked patent?

SOPA Opera: La distruzione di Khanna

By: Saturday December 8, 2012 4:00 pm

Act 1: Delight

For the glory of Summer we are punished with Fall. So it was that on November 16th, 2012 the Republican Study Committee offered a bold proposal to reform America’s ridiculous copyright system titled Three Myths About Copyright Law and Where To Fix It. The contact and alleged driving force behind the document was Derek Khanna a staffer at the RSC.

The policy brief was nothing short of a full frontal double barreled blast at Copyright Trolls (also known as the entertainment industry).

CSM Ads advertisement
Advertisement
FOLLOW FIREDOGLAKE
LATEST FROM AROUND FIREDOGLAKE
Upcoming FDL Book Salons

Saturday, April 19, 2014
2:00 pm Pacific
Poison Candy: The Murderous Madam: Inside Dalia Dippolito’s Plot to Kill
Chat with Mark Ebner about his new book. Hosted by Beth Karas.

Sunday, April 20, 2014
2:00 pm Pacific
The Gulf of Tonkin Events – Fifty Years Later: A Footnote to the History of the Vietnam War
Chat with John White about his new book. Hosted by Pulitzer Prize winner Deborah J. Nelson.


Close